News
AbbVie Inc.'s Q1 earnings highlight an 8.4% revenue boost, driven by Skyrizi & Rinvoq. Click for ABBV's market expansion, ...
The Canadian Press on MSN1d
Transplant recipients and other immunocompromised people worry about measles exposureLaurie Miller, a 59-year-old heart transplant patient exposed to measles in Stratford, Ont., says her story speaks to the ...
In this article, we are going to take a look at where ADMA Biologics, Inc. (NASDAQ:ADMA) stands against other best multibagger stocks to buy according to billionaires. US Trade tariffs have ...
Recorded Q1'25 consolidated revenue of KRW 1.3 trillion Recorded Q1'25 consolidated operating profit of KRW 486.7 billion Company expected to maintain steady growth momentum in 2025 driven by ...
Axial spondyloarthritis (axSpA) clinical trials showed improved diversity, with increased representation of Asian and Hispanic/Latino participants. However, Black and Native Hawaiian/Pacific ...
Theriva Biologics, Inc, a clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States. The company’s lead product ...
HCW Biologics Inc. (NASDAQ:HCWB), a pharmaceutical company, is embroiled in legal challenges related to its new headquarters and manufacturing facilities’ construction and renovation.
SEOUL, South Korea, April 23, 2025 /PRNewswire/ -- LOTTE BIOLOGICS (CEO James Park) announced on April 24 (KST) that it has signed a manufacturing agreement with an Asia-based biotech company for ...
Samsung Biologics Logo (PRNewsfoto/Samsung Biologics) "We sustained solid momentum in the first quarter, supported by the efficient operations across all our plants and continued partnerships with our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results